Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

2,8-dibenzylcyclooctanone

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1976
1976
Abstract Male rats were given orally 2,8-dibenzylcyclooctanone (DBCO) at doses ranging from 0.3 to 30 mg/kg/day for 1–6 weeks… Expand
Is this relevant?
1976
1976
A number of 2,8-dibenzylcyclooctanone analogues inhibited the HMG-CoA reductases activity of Holtzman male rat liver, whereas… Expand
Is this relevant?
1976
1976
Aliphatic analogs of 2,8-dibenzylcyclooctanone which includes C15-C18 ketones have been investigated for hypocholesterolemic… Expand
Is this relevant?
1976
1976
The effects of 2,8-dibenzylcyclooctanone (DBCO) and a series of its analogues on serum lipids and on estrogenic activity in… Expand
Is this relevant?
1975
1975
A series of 19 aliphatic analogs of 2,8-dibenzylcyclooctanone and 1,5-diphenyl-2,4-dimethyl-3-pentanone was examined. Separation… Expand
Is this relevant?
1975
1975
The 14-C-labeled 2,8-dibenzylcyclooctanone was synthesized to study its absorption, distribution, and excretion in rats. Maximum… Expand
Is this relevant?
1975
1975
Fluoro and hydroxy derivatives of 2,8-dibenzylcyclooctanone were prepared. Separation of antifertility activity from… Expand
Is this relevant?